LLY Lilly(Eli) & Company

  1. Stocks
  2. Healthcare
  3. NYSE: LLY

Price (delayed)

$1,141.57

Market cap

$1.08T

P/E Ratio

40.5

Dividend/share

$6.46

EPS

$28.19

Enterprise value

$1.11T

?
Relative Growth: Rel. Growth: 99
Relative Strength: Rel. Strength: 80
Relative Valuation: Rel. Valuation: 43
Relative Profitability: Rel. Profitability: 99

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of ...

Highlights
The net income has soared by 128% YoY and by 22% from the previous quarter
The EPS has soared by 128% YoY and by 23% QoQ
The quick ratio has increased by 26% year-on-year but it has declined by 8% since the previous quarter
Lilly(Eli)'s debt has increased by 13% YoY and by 2% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.lilly.com
Peers: BMY MRK JNJ PFE

Key stats

What are the main financial stats of LLY

LLY stock price

How has the Lilly(Eli) stock price performed over time
Intraday
-0.63%
1 week
-4.67%
1 month
-5.96%
1 year
49.75%
YTD
6.22%
QTD
-4.82%

Financial performance

How have Lilly(Eli)'s revenue and profit performed over time
Revenue
$72.25B
Gross profit
$59.84B
Operating income
$31.76B
Net income
$25.28B
Gross margin
82.8%
Net margin
35%
The net income has soared by 128% YoY and by 22% from the previous quarter
LLY's operating income has surged by 126% year-on-year and by 21% since the previous quarter
Lilly(Eli)'s net margin has soared by 54% YoY and by 10% from the previous quarter
Lilly(Eli)'s operating margin has soared by 53% YoY and by 9% from the previous quarter

Price vs fundamentals

How does LLY's price correlate with its fundamentals

Growth

What is Lilly(Eli)'s growth rate over time

Valuation

What is Lilly(Eli) stock price valuation
LLY P/E details
P/E
40.5
P/B
34.52
P/S
14.13
EV/EBIT
35.76
EV/EBITDA
33.56
EV/Sales
15.41
The EPS has soared by 128% YoY and by 23% QoQ
The P/E is 36% below the 5-year quarterly average of 63.8 and 2.5% below the last 4 quarters average of 41.8
The equity has surged by 98% year-on-year and by 18% since the previous quarter
LLY's P/B is 14% below its 5-year quarterly average of 40.6
Lilly(Eli)'s revenue has increased by 47% YoY and by 11% from the previous quarter
The stock's price to sales (P/S) is 12% more than its last 4 quarters average of 12.7 and 6% more than its 5-year quarterly average of 13.4

Efficiency

How efficient is Lilly(Eli) business performance
The ROIC has soared by 63% YoY and by 14% from the previous quarter
The ROA has soared by 61% YoY and by 15% from the previous quarter
The ROS has soared by 55% YoY and by 9% QoQ
The company's return on equity rose by 32% YoY and by 3.5% QoQ

Dividends

What is LLY's dividend history
Dividend details
DPS
$6.46
Dividend yield
0.57%
Payout ratio
22.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Lilly(Eli) financials performed over time
LLY's total assets is 37% greater than its total liabilities
LLY's total assets is up by 30% year-on-year and by 3.6% since the previous quarter
The quick ratio has increased by 26% year-on-year but it has declined by 8% since the previous quarter
Lilly(Eli)'s debt is 39% more than its equity
The equity has surged by 98% year-on-year and by 18% since the previous quarter
The company's debt to equity fell by 43% YoY and by 13% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.